Datwyler to Double Capacity at Production Ops in Pune

Datwyler, a manufacturer of system-critical elastomer components for pharmaceutical packaging, will nearly double capacity at its production operation in Pune, India, and add 400 jobs in the near future. By starting up a second plant on the premises in the third quarter 2022, Datwyler will increase output significantly to meet growing global demand. 

Datwyler has been operating all three production standards at its Indian site: Essential, Advanced and FirstLine. Examples for the FirstLine Standard are OmniFlex stoppers for use in vials for global distribution. FirstLine is an advanced manufacturing concept specially designed to manufacture pharmaceutical rubber components for the high-end pharmaceutical and biotech markets. It is designed to meet the highest quality assurance in the production of critical components for pharmaceutical packaging. The operation encompasses ultra-modern cleanroom technology, automated production cells, automated camera inspection, and a unique validated washing process.

“We are excited to  start up the second plant at our Pune site in these days and proud to significantly expand our capacity,” said Dirk Borghs, Head of the Datwyler Healthcare business.
The expansion will enable Datwyler to continuously relocate Essential and Advanced production units from the first plant to the new second plant. As a result, there will be free space in the first plant, which will make it possible to expand production capacity for the FirstLine standard.

“The impetus for the expansion at the Pune facility comes from the demand generated for critical pharmaceutical packaging components as the injectables market grows rapidly,” said Rahul Dev, Datwyler Senior VP of Global Operations Healthcare Solutions.